Firms

Pavilion Capital

Singapore

sevioracapital.com

sevioragroup.com

pavcap.com.sg

Pavilion Capital is a Singapore-based private equity fund-of-funds and co-investment platform established in 2012 within the Temasek ecosystem. Its historic investment manager was Pavilion Capital International Pte. Ltd., with Pavilion Capital Holdings, its general partner and fund or investment subsidiaries legally distinct. The franchise invests across Asian markets, including innovative technology and healthcare, through fund commitments, direct investments, co-investments and secondaries. Pavilion Capital amalgamated into Seviora Capital in 2026 and continues as the Pavilion Capital Investments platform; the retained brand and published team distinguish it from other Seviora strategies. Founding CEO Tow Heng Tan retired on 31 March 2026, while Danny Wong heads the Pavilion investment group and Ong Lui Chun leads its investment team. Its verified AI-related investments include Engine Biosciences and Schrödinger. The unrelated New York Pavilion Capital Partners at pavilioncapital.com, Pavilion Energy and Pavilion Data are separate businesses. Seviora group AUM and Pavilion historic balance-sheet assets are not recorded as fund-close proceeds.

Founded: 2012
Type: Venture capital

Funds3

PavCap Fund I——
Actual Cayman Islands fund identified in a December 2020 SEC Schedule 13G, managed by Pavilion Capital International Pte. Ltd. and wholly owned by PavCap I Feeder No. 1 LP. Legal fund existence and manager are verified; cash close size and exact launch day are undisclosed. The feeder is a related legal vehicle rather than an additional summable fundraise.
PavCap I Feeder No. 1 LP——
Actual Singapore limited partnership feeder for PavCap Fund I, acting through Pavilion Capital GP Pte. Ltd. and managed by Pavilion Capital International Pte. Ltd. The fund and feeder capital must not be added together. Verified legal vehicle, with no public closed fundraising amount or exact launch day verified.
PavCap Japan Fund——
Japan-focused fund established in 2020 according to Temasek’s July 2021 primary review. Strategy covers mid-cap direct investments and other Japan-focused private equity funds. Year-only launch is retained in this description; a final-close amount or exact announcement date was not verified.

Team

Operations and support

Chew Jun ShengManager (Pavilion Capital Investments team within Seviora Capital)

Danny WongHead of Investment Group, Pavilion Capital Investments

Faisal RamleeManager (Pavilion Capital Investments team within Seviora Capital)

Gideon ChanManager (Pavilion Capital Investments team within Seviora Capital)

Goh Qing KaiManager (Pavilion Capital Investments team within Seviora Capital)

Ho Sheng YungSenior Associate (Pavilion Capital Investments team within Seviora Capital)

Ian LongHead of Korea, Pavilion Capital Investments

Jean ChewAssociate (Pavilion Capital Investments team within Seviora Capital)

Jenessa HoDirector (Pavilion Capital Investments team within Seviora Capital)

Kenneth TongAssociate Director (Pavilion Capital Investments team within Seviora Capital)

Kenneth WongDirector (Pavilion Capital Investments team within Seviora Capital)

Khor Boon HowHead of India, Pavilion Capital Investments

Kwok LihDirector (Pavilion Capital Investments team within Seviora Capital)

Lee Yann FangHead of Japan, Pavilion Capital Investments

Li See WengAssociate (Pavilion Capital Investments team within Seviora Capital)

Lloyd LimHead of China, Pavilion Capital Investments

Melissa LinDirector (Pavilion Capital Investments team within Seviora Capital)

Ng ShufeiDirector (Pavilion Capital Investments team within Seviora Capital)

Ong Lui ChunManaging Director, Pavilion Capital Investments

Phillips HuangDirector (Pavilion Capital Investments team within Seviora Capital)

Phua Zai JieManager (Pavilion Capital Investments team within Seviora Capital)

Sam ChenManager (Pavilion Capital Investments team within Seviora Capital)

Shaun LimManager (Pavilion Capital Investments team within Seviora Capital)

Wei MingjianAssociate (Pavilion Capital Investments team within Seviora Capital)

Investments

$110M2019-05-19	Schrödinger	WuXi AppTec, The Invus Group, LLC, Laurion Capital Management, Deerfield, GV, Pavilion Capital
$10M2018-01-31	Engine Biosciences	6 Dimensions Capital, DHVC (Danhua Capital), Pavilion Capital, Nest.Bio Ventures, EDBI, WI Harper Group, Baidu Ventures, WuXi AppTec

team@apexlogos.ai18 hours ago
Reviewed 7 October 2026. Pavilion Capital’s 2018 Engine Biosciences buyer identity is the Temasek-owned Singapore platform, separate from New York Pavilion Capital Partners. Current primary sources confirm 2026 amalgamation into Seviora Capital, with the Pavilion brand retained. All 24 Pavilion-linked investment professionals from the current native directory have original portraits and scoped roles; other Seviora staff were excluded. Tow Heng Tan retired 31 March 2026 and is not recorded as current CEO. Three actual legal fund/feeder vehicles are documented with unknown close amounts; master and feeder are not summable fundraising. Seviora’s $9.6 billion AUM, broader group AUM, revenue, balance sheet and fund commitments to other managers are not newly raised Pavilion funds. Engine batch 521 owns its exact seed participation. Batch 533 owns only the separately verified Schrödinger Series E callback after precise primary evidence and duplicate checks.

Funds3

Team

Operations and support

Co-investing

Investments